Table 1 Clinical characteristics of the patients with LIHC
From: DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
Characteristic | Levels | Overall (%) |
|---|---|---|
Age, n (%) | ≤ 60 | 177 (47.5) |
|  | > 60 | 196 (52.5) |
Gender, n (%) | Female | 121 (32.4) |
| Â | Male | 253 (67.6) |
Race, n (%) | Asian | 160 (44.2) |
| Â | Black or African American | 17 (4.7) |
| Â | White | 185 (51.1) |
Pathologic stage, n (%) | Stage I | 173 (49.4) |
| Â | Stage II | 87 (24.9) |
| Â | Stage III | 85 (24.3) |
| Â | Stage IV | 5 (1.4) |
T stage, n (%) | T1 | 183 (49.3) |
| Â | T2 | 95 (25.6) |
| Â | T3 | 80 (21.6) |
| Â | T4 | 13 (3.5) |
N stage, n (%) | N0 | 254 (98.4) |
| Â | N1 | 4 (1.6) |
M stage, n (%) | M0 | 268 (98.5) |
| Â | M1 | 4 (1.5) |
Histologic grade, n (%) | G1 | 55 (14.9) |
| Â | G2 | 178 (48.2) |
| Â | G3 | 124 (33.6) |
| Â | G4 | 12 (3.3) |
Adjacent hepatic tissue inflammation, n (%) | None | 118 (49.8) |
| Â | Mild | 101 (42.6) |
| Â | Severe | 18 (7.6) |
AFP(ng/ml), n (%) | ≤ 400 | 215 (76.8) |
|  | > 400 | 65 (23.2) |
Child-Pugh grade, n (%) | A | 219 (90.9) |
| Â | B | 21 (8.7) |
| Â | C | 1 (0.4) |